Experimental drug can reduce breast-cancer aggressiveness, restore drug-sensitivity

[News]

A new study led by researchers at The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC - James) suggests that an unusual experimental drug can reduce breast-cancer aggressiveness, reverse resistance to the drug fulvestrant and perhaps improve the effectiveness of other breast-cancer drugs.

More... (http://www.news-medical.net/news/20130423/Experimental-drug-can-reduce-breast-cancer-aggressiveness-restore-drug-sensitivity.aspx)